<unk>  is a xanthine oxidase (XO) inhibitor that is FDA approved for the {{{indicationType}}} of hyperuricemia in patients with gout.   Common adverse reactions include liver function abnormalities, nausea, arthralgia, and rash.
Febuxostat
Vorinostat
Rasburicase
Bosutinib
Ruxolitinib
Tofacitinib
Gilteritinib
Aldesleukin